Frontlight ResearchEarly access
Active, not recruitingNo phase
Continuous And Data-drivEN CarE (CADENCE) Pilot
Key facts
- Who runs it
- University of South Florida
- Where
- Tampa, United StatesSee the site
- Trial code
- Status
- Active, not recruiting
- People taking part
- 10 people, planned
- Started
- 23 Aug 2023
- Expected to end
- 30 Sept 2027
- Type of study
- Interventional
- Treatments tested
- CADENCE program
- Record updated
- 10 November 2025
Who can take part
- Age
- 18 years and older
- Sex
- Women only
- Healthy volunteers
- Cannot take part
Show the full registry criteria (2)Hide the full registry criteria
Who can take part
- Patients with known opioid use disorder over the age of 18 years old who are pregnant
Who cannot take part
- Patients without opioid use disorder, less than 18 years old, incarcerated, or non-pregnant
Where in United States
- University of South Florida (Tampa General Hospital)Tampa, United States
About the trial
What the trial wants to find out
The proposed project seeks to use public health and clinical data on opioid use disorders (OUD) outcomes for mother and infants, which is the leading cause of death to mothers one year after deliver and can lead to neonatal withdrawal syndrome (NOWS) and other poor outcomes. Insufficient or incomplete data about OUD and lack of integrated programs for OUD treatment during pregnancy can be barriers to providing optimal care to mothers and infants.
The group in the trial
- CADENCE program pilotTreatment being tested
Treatment: CADENCE program
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Continuous And Data-drivEN CarE (CADENCE)
- Publications
- Referral linkages to support pregnant and postpartum individuals with opioid use disorders in Florida: a social network analysis.Addiction science & clinical practice, 2026
- Record updated
- 10 November 2025